###begin article-title 0
###xml 60 78 60 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="N0x1ca2bb0N0x2a18b10">&#9734;</xref>
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fn" rid="N0x1ca2bb0N0x2a18b10">&#9734;</xref></sup>
###xml 60 78 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Casein kinase 1 isoform 2 is essential for bloodstream form Trypanosoma bruceiâ˜†
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
###xml 116 143 116 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei in vitro</italic>
###xml 353 362 353 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 409 417 409 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 460 476 460 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 116 134 <span type="species:ncbi:5691">Trypanosoma brucei</span>
###xml 353 362 <span type="species:ncbi:5691">T. brucei</span>
###xml 460 476 <span type="species:ncbi:562">Escherichia coli</span>
Induction of RNA interference targeted against casein kinase 1 isoform 2 (TbCK1.2, Tb927.5.800) in bloodstream form Trypanosoma brucei in vitro results in rapid cessation of growth, gross morphological changes, multinucleation and ultimately cell death. A null mutant of the highly homologous casein kinase 1 isoform 1 (Tb927.5.790) in bloodstream form T. brucei displays no growth or morphological phenotype in vitro. A truncated form of TbCK1.2 expressed in Escherichia coli as a GST fusion produces catalytically active recombinant protein, facilitating screening for small molecule inhibitors. These data show that TbCK1.2 is an attractive target for anti-trypanosomal drug discovery.
###end p 3
###begin title 4
Abbreviations
###end title 4
###begin title 5
Keywords
###end title 5
###begin p 6
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 206 209 206 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">[1]</xref>
###xml 401 404 401 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">[2]</xref>
###xml 566 575 566 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 608 611 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr">[3]</xref>
###xml 743 746 743 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">[4]</xref>
###xml 0 18 <span type="species:ncbi:5691">Trypanosoma brucei</span>
###xml 74 80 <span type="species:ncbi:9606">humans</span>
###xml 566 575 <span type="species:ncbi:5691">T. brucei</span>
Trypanosoma brucei is the causative agent of African sleeping sickness in humans, and current treatments are expensive, toxic, and difficult to administer, leaving an urgent need for new therapeutic agents [1]. Drug discovery programs for African sleeping sickness have recently started in academia, but there remains a need to identify, validate and characterise new drug targets to feed this effort [2]. Protein kinases (PKs), key mediators of growth and cell signalling, are one of the major drug target families being tackled by the pharmaceutical industry. The T. brucei genome encodes 176 putative PKs [3], which are in theory attractive targets for anti-trypanosomal drug discovery, given the possibility of 'piggy-back' drug discovery [4].
###end p 6
###begin p 7
###xml 271 276 271 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib6" ref-type="bibr">[5,6]</xref>
###xml 550 553 550 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr">[7]</xref>
The serine/threonine protein kinase casein kinase I family (CK1s) plays an important role in eukaryotic signalling pathways, and their substrates include key regulatory protein involved in cell differentiation, proliferation, chromosome segregation and circadian rhythms [5,6]. Essential CK1s are attractive targets for anti-trypanosomal drug discovery as CK1s are monomeric, constitutively active and usually co-factor independent, simplifying assay development, and there are several high resolution structures of CK1s with ATP or inhibitors bound [7] to aid rational drug design.
###end p 7
###begin p 8
###xml 4 20 4 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania major</italic>
###xml 163 168 163 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib9" ref-type="bibr">[8,9]</xref>
###xml 224 233 224 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 264 273 264 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 447 456 447 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 4 20 <span type="species:ncbi:5664">Leishmania major</span>
###xml 224 233 <span type="species:ncbi:5691">T. brucei</span>
###xml 264 273 <span type="species:ncbi:5691">T. brucei</span>
###xml 447 456 <span type="species:ncbi:5691">T. brucei</span>
The Leishmania major CK1 isoform 2 (LmCK1.2, LmjF35.1010) has been implicated as an essential enzyme through studies using immobilized or radiolabelled inhibitors [8,9]. The same compounds were also shown to be cytotoxic to T. brucei, implying that the homologous T. brucei enzyme (TbCK1.2) may also be essential. Here, we demonstrate that TbCK1.2 is an attractive drug target by establishing its essentiality for the survival of bloodstream form T. brucei, and demonstrating that functional recombinant protein can be obtained to facilitate screening for inhibitors.
###end p 8
###begin p 9
###xml 108 117 108 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 128 136 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 148 156 148 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. major</italic>
###xml 156 159 156 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr">[3]</xref>
###xml 195 202 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib11" ref-type="bibr">[10,11]</xref>
###xml 228 237 228 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 108 117 <span type="species:ncbi:5691">T. brucei</span>
###xml 128 136 <span type="species:ncbi:5693">T. cruzi</span>
###xml 148 156 <span type="species:ncbi:5664">L. major</span>
###xml 228 237 <span type="species:ncbi:5691">T. brucei</span>
Recent bioinformatic analysis of the trypanosomatid genomes for the presence of PKs identified four CK1s in T. brucei, seven in T. cruzi and six in L. major[3]. Analysis of the protein sequences [10,11] revealed that two of the T. brucei CK1 proteins are highly homologous to the putatively essential LmCK1.2 (LmjF35.1010), namely TbCK1.2 (Tb927.5.800, 76% identity) and TbCK1.1 (Tb927.5.790, 62% identity). The TbCK1.1 and TbCK1.2 proteins are 72% identical to each other and occur on adjacent ORFs, raising the possibility that they may be functionally redundant. However, TbCK1.2 contains an unusual QQQQQQQQQQ motif located close to the C-terminus that is not present in either TbCK1.1 or LmCK1.2.
###end p 9
###begin p 10
###xml 89 98 89 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 111 118 111 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 272 279 272 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">[12]</xref>
###xml 711 718 711 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 737 749 733 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1::PAC</italic>
###xml 755 767 747 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1::HYG</italic>
###xml 861 868 853 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 896 903 888 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 976 983 968 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 989 996 981 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 1100 1106 1092 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1154 1162 1146 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 89 98 <span type="species:ncbi:5691">T. brucei</span>
In order to investigate the essentiality of TbCK1.1 for the survival of bloodstream form T. brucei the haploid TbCK1.1 genes were replaced with drug resistance genes by homologous recombination. Approximately 500 bp of the 5'- and 3'-UTR sequences immediately adjacent to TbCK1.1 were PCR amplified from genomic DNA using primers that allowed the two products to be knitted together in a second PCR to create a restriction enzyme site between the UTRs, allowing a drug resistance gene to be inserted [12]. The puromycin acetyltransferase (PAC) and hygromycin phosphotransferase (HYG) drug resistance genes were inserted between the UTRs and the resulting constructs used sequentially to replace both alleles of TbCK1.1 generating a DeltaTbCK1.1::PAC/DeltaTbCK1.1::HYG double knockout (dKO) cell line. Reverse transcriptase-PCR (RT-PCR) confirmed the absence of TbCK1.1 mRNA and revealed that the TbCK1.2 mRNA level was not significantly upregulated in response to the loss of TbCK1.1. The TbCK1.1 dKO cell line had normal morphology (not shown) and its growth was unaltered compare to the wild type (Fig. 1A), demonstrating that TbCK1.1 is not essential in vitro.
###end p 10
###begin p 11
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 74 83 74 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 205 212 205 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 253 265 249 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2::PAC</italic>
###xml 274 286 266 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1::HYG</italic>
###xml 406 413 398 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 488 494 480 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TABlue</sup>
###xml 502 506 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">[13]</xref>
###xml 590 597 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 700 707 692 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 753 760 745 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 767 773 759 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 796 803 788 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 845 851 837 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 904 910 896 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1116 1123 1108 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 1273 1277 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">[12]</xref>
###xml 74 83 <span type="species:ncbi:5691">T. brucei</span>
The essentiality of the TbCK1.2 gene for the survival of bloodstream form T. brucei was initially examined using the same methodology as applied to TbCK1.1. Although gene replacement of a single allele of TbCK1.2 with either PAC or HYG to generate DeltaTbCK1.2::PAC or DeltaTbCK1.1::HYG single knockout cell lines was successful, the replacement of the second allele failed. To confirm the essentiality of TbCK1.2, several tetracycline-inducible RNAi cell lines were produced using a p2T7TABlue vector [13] containing a 320-bp insert composed of 80-bp of 5'-UTR and the first 240-bp of the TbCK1.2 ORF. After induction of RNAi by addition of tetracycline, RT-PCR confirmed a significant reduction in TbCK1.2 mRNA levels with only a marginal decrease in TbCK1.1 mRNA (Fig. 1B, inset). Ablation of TbCK1.2 mRNA produced rapid cessation of growth (Fig. 1B), gross morphological changes and multinucleation (Fig. 1C), and ultimately cell death. Occasionally, so-called 'revertant' cells were observed, where, after an initial period of cell death, the growth of the cultures resumed. In such cases, RT-PCR revealed that TbCK1.2 mRNA level had returned to wild type level in the revertant cells (not shown), suggesting spontaneous loss of tetracycline control may have occurred [12].
###end p 11
###begin p 12
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
###xml 572 577 572 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib6" ref-type="bibr">[5,6]</xref>
Taken together, these data demonstrate that the highly homologous casein kinases TbCK1.1 and TbCK1.2 are non-redundant, and that only TbCK1.2 is essential for the bloodstream form of the parasite in vivo. Knockdown of TbCK1.2 rapidly produces "monster" cells with gross morphological changes and multinucleation that clearly result from loss of cell cycle control; however, this does not necessarily indicate a direct role for CK1 in cytokinesis, as this phenotype may be the result of indirect effects [14]. As CK1s are known to be involved in diverse cellular processes [5,6], detailed analysis of the morphological changes induced by TbCK1.2 knockdown is unlikely to give a clear picture of the underlying biology. Instead, identifying the proteins that are phosphorylated by TbCK1.2, and the effect of such phosphorylation, may offer the best approach to understanding the cellular roles of TbCK1.2.
###end p 12
###begin p 13
###xml 285 290 285 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib6" ref-type="bibr">[5,6]</xref>
###xml 462 479 462 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 462 479 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
###xml 503 508 <span type="species:ncbi:9606">human</span>
Despite the high level of sequence homology between TbCK1.1 and TbCK1.2, they are clearly functionally non-redundant. Typically, CK1 family members differ mainly in their non-kinase N- and C-terminal extensions, which have been proposed to influence localization and modulate activity [5,6]. TbCK1.2 contains an unusual C-terminal QQQQQQQQQQ motif that is absent from both TbCK1.1 and LmCK1.2, and although a similar C-terminal Q-rich region is found in several Trypanosoma cruzi CK1s (QQEQKQQQQQQ) and human CK1alpha (QGQQAQ), nothing is known about its significance.
###end p 13
###begin p 14
###xml 53 69 53 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 103 106 103 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr">[9]</xref>
###xml 264 289 264 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schizosaccharomyces pombe</italic>
###xml 391 394 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr">[7]</xref>
###xml 588 595 576 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 613 616 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 53 69 <span type="species:ncbi:562">Escherichia coli</span>
###xml 264 289 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 588 595 <span type="species:ncbi:562">E. coli</span>
Full length LmCK1.2 has previously been expressed in Escherichia coli as an active recombinant protein [9], however attempts to express full length TbCK1.2 produced little soluble protein. A truncated form of TbCK1.2 was designed based on the crystal structure of Schizosaccharomyces pombe Cki1Delta298, a truncated and active CK1 where 148 amino acids have been removed from the C-terminus [7]. The truncation of TbCK1.2, termed TbCK1.2Delta298, eliminates the C-terminal 34 amino acids including the unusual QQQQQQQQQQ motif. Expression of TbCK1.2Delta298 as a C-terminal GST fusion in E. coli and purification via immobilised glutathione produced a 61 kDa soluble protein whose identity was confirmed by tryptic peptide mass fingerprinting.
###end p 14
###begin p 15
###xml 501 503 481 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 876 877 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 877 884 845 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m(app.)</sub>
###xml 889 890 857 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 890 899 858 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max(app.)</sub>
###xml 952 959 920 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
An inactive 'kinase-dead' form of TbCK1.2Delta298 was created by using site directed mutagenesis to alter the active site aspartate 133 to alanine (D133A), and was expressed and purified under identical conditions to the wild type protein. The ability of TbCK1.2Delta298 and TbCK1.2Delta298-D133A to phosphorylate myelin basic protein, partially dephosphorylated alpha-casein, a CK1 peptide substrate (RRKDLHDDEEDEAMSITA) and a CK1 phosphopeptide substrate (KRRRALS(p)VASLPGL) was measured in a gamma[33P]-ATP filter plate assay. No autophosphorylation was observed, and whilst TbCK1.2Delta298 phosphorylated every substrate apart from MBP, the D133A 'kinase-dead' mutant was inactive, confirming that the catalytic activity observed was due to TbCK1.2Delta298 and not a contaminant. Determination of the kinetic parameters for TbCK1.2Delta298 kinase activity revealed modest Km(app.) and Vmax(app.) compared to those reported for recombinant LmCK1.2 (Table 1), suggesting that the optimal substrates for TbCK1.2 have not yet been identified.
###end p 15
###begin p 16
###xml 113 121 103 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 176 183 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 205 208 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">[6]</xref>
###xml 270 279 260 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 388 392 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 437 445 427 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 663 670 649 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 270 279 <span type="species:ncbi:5691">T. brucei</span>
Autophosphorylation of the C-terminus of CK1delta and CK1epsilon has been shown to down regulate kinase activity in vitro, although such phosphorylation is efficiently removed in vivo to maintain activity [6]. A recent proteome wide analysis of phosphorylation sites in T. brucei identified TbCK1.2 as being phosphorylated at the S19 position, with no C-terminal phosphorylation observed [16]. We did not observe any autophosphorylation in vitro with TbCK1.2Delta298, although the recombinant protein does lack the native C-terminus. If the phosphorylation of TbCK1.2 occurring at S19 is not due to autophosphorylation, it suggests that TbCK1.2 is phosphorylated in vivo by an upstream kinase that might modulate its activity.
###end p 16
###begin p 17
###xml 117 126 117 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 117 126 <span type="species:ncbi:5691">T. brucei</span>
In summary, we have demonstrated that TbCK1.2 is an essential enzyme for the clinically relevant bloodstream form of T. brucei, and have been able to obtain active and assayable recombinant protein. Whilst there is still much to learn about the biological role of TbCK1.2, these findings make TbCK1.2 an attractive target for antiparasitic drug discovery, as high-throughput screening for PK inhibitors is well established and should be readily adapted to a new kinase.
###end p 17
###begin title 18
Acknowledgements
###end title 18
###begin p 19
###xml 94 100 94 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TABlue</sup>
I thank David Horn, London School of Hygiene & Tropical Medicine for the kind gift of the p2T7TABlue plasmid and associated protocols, Rafaela Grimaldi, University of Dundee for assistance with the kinase activity assays, and the Cloning Service and the Proteomic Facility at the College of Life Science, University of Dundee. I am grateful to Michael A.J. Ferguson, University of Dundee for his support and helpful discussions. This work was supported by a Wellcome Trust programme grant (071463).
###end p 19
###begin p 20
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note:</italic>
Note: Nucleotide sequence data reported in this paper are available in the GeneBanktrade mark, EMBL and DDBJ databases under the accession numbers  and .
###end p 20
###begin title 21
References
###end title 21
###begin article-title 22
African Trypanosomiasis
###end article-title 22
###begin article-title 23
Target assessment for antiparasitic drug discovery
###end article-title 23
###begin article-title 24
###xml 73 89 <span type="species:ncbi:5664">Leishmania major</span>
###xml 91 109 <span type="species:ncbi:5691">Trypanosoma brucei</span>
###xml 114 131 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi
###end article-title 24
###begin article-title 25
Protein kinases as drug targets in Trypanosomes and Leishmania
###end article-title 25
###begin article-title 26
The casein kinase 1 family: participation in multiple cellular processes in eukaryotes
###end article-title 26
###begin article-title 27
Casein kinase I: from obscurity to centre stage
###end article-title 27
###begin article-title 28
Crystal structure of casein kinase-1, a phosphate-directed protein kinase
###end article-title 28
###begin article-title 29
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors
###end article-title 29
###begin article-title 30
###xml 50 66 <span type="species:ncbi:5664">Leishmania major</span>
Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro
###end article-title 30
###begin article-title 31
###xml 2 8 <span type="species:ncbi:13443">Coffee</span>
T-Coffee: a novel method for multiple sequence alignment
###end article-title 31
###begin article-title 32
EMBOSS: The European Moelcular Biology Open Software Suite
###end article-title 32
###begin article-title 33
###xml 77 95 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei
###end article-title 33
###begin article-title 34
###xml 86 104 <span type="species:ncbi:5691">Trypanosoma brucei</span>
A doubly inducible system for RNA interference and rapid RNAi plasmid construction in Trypanosoma brucei
###end article-title 34
###begin article-title 35
Cytokinesis in trypanosomatids
###end article-title 35
###begin article-title 36
###xml 72 90 <span type="species:ncbi:5691">Trypanosoma brucei</span>
RNAit: an automated web-based tool for the selection of RNAi targets in Trypanosoma brucei
###end article-title 36
###begin p 37
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 89 96 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 192 199 192 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 204 211 204 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 239 246 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 391 398 391 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 534 546 530 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1::PAC</italic>
###xml 552 564 544 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1::HYG</italic>
###xml 633 640 625 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 692 699 684 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 718 722 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">[15]</xref>
###xml 834 840 826 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAblue</sup>
###xml 870 874 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">[13]</xref>
###xml 1053 1060 1045 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.1</italic>
###xml 1111 1118 1103 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbCK1.2</italic>
###xml 1402 1403 1393 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Growth and morphology of TbCK1.1 knockout and TbCK1.2 knockdown cells. (A) Growth of the TbCK1.1 double knockout (dKO) cell line compared to wild type (WT), inset shows the RT-PCR analysis of TbCK1.1 and TbCK1.2 mRNA levels; (B) growth of TbCK1.2 knockdown cells in the absence (-Tet) and presence (+Tet) of tetracycline, with RT-PCR inset; (C) Phase contrast and DAPI-stained microscopy of TbCK1.2 knockdown cells cultured in the absence (-Tet) and presence (+Tet) of tetracycline for 48 h, arrows indicate multinucleation. The DeltaTbCK1.1::PAC/DeltaTbCK1.1::HYG dKO cell line was created by homologous recombination. Knockdown of TbCK1.2 by tetracycline inducible RNAi was achieved with a TbCK1.2 specific fragment [15] PCR-amplified from genomic DNA (primers 5'-GACAGCGGCAATAATCC-3' and 5'-CCACAACACCGCCAC-3') and cloned into p2T7TAblue as described by Alibu et al. [13]. RT-PCR was performed using the Quick-Access RT-PCR system (Promega) using a common 5'-primer (5'-TGGCAGGGTTAAAGGC-3') with two unique 3'-primers producing a 345 bp fragment for TbCK1.1 (5'-GACGGGATGTTCATC-3') and a 320 bp fragment for TbCK1.2 (5'-TCGGTGTCATCACTC-3'). Microscopy was performed using cell fixed in 4% paraformaldehyde and stained with 2 mug/ml DAPI, with images acquired on a Zeiss Axiovert 200 M fluorescence microscope. Growth curves and microscopy images are representative examples of multiple experiments (n >/= 3).
###end p 37
###begin p 38
Kinetic parameters for TbCK1.2Delta298 and LmCK1.2.
###end p 38
###begin p 39
NA: not available.
###end p 39
###begin p 40
###xml 92 99 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 725 727 701 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 793 794 769 770 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 895 897 865 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 1029 1030 998 999 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1032 1033 1001 1002 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1132 1133 1101 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1135 1136 1104 1105 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 92 104 <span type="species:ncbi:511693">E. coli BL21</span>
Recombinant GST tagged TbCK1.2Delta298 was obtained by expression from a pGEX-6P1 vector in E. coli BL21(DE3)pLysS (Novagen). Briefly, cells were induced with 250 muM IPTG for 18 h at 16 degreesC, resuspended in buffer A (50 mM Tris pH 8.0, 250 mM NaCl, 0.1% beta-mercaptoethanol, 0.2 mM PMSF, 1 mM benzamidine) supplemented with 1% Triton TX100, 1 mM EDTA and 1 mM EGTA, and lysed by sonication. The GST tagged protein was bound to glutathione sepharose, washed extensively with wash buffer (buffer A, 0.03% Brij, 0.1 mM EGTA), eluted with wash buffer supplemented with 20 mM glutathione, dialysed against wash buffer supplemented with 10% glycerol (v/v), and stored at -80 degreesC. Phosphorylation was measured in a gamma[33P]-ATP filter plate assay. Briefly, 25 mM HEPES pH 7.4, 16 mM MgCl2, 5 mM glycerophosphate, 1 mM DTT, 0.4 mg/ml BSA and 30 muM ATP was supplemented with 1.5 muCi gamma[33P]-ATP, 50 nM kinase, and 0-112.5 muM substrate and the reaction allowed to proceed for 1 h. Reactions were stopped by addition of H3PO4, the phosphorylated substrates captured on a P81 filter plate (Whatman), washed three times with H3PO4, the plates dried, and the radioactivity counted on a Topcount NXT scintillation counter (PerkinElmer).
###end p 40
###begin p 41
###xml 57 60 57 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr">[9]</xref>
Values for recombinant LmCK1.2 taken from Allocco et al. [9].
###end p 41
###begin p 42
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 12 19 12 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m(app.)</sub>
###xml 30 31 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 31 40 30 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max(app.)</sub>
Values for Km(app.) (muM) and Vmax(app.) (nmol/(min mg)) were calculated using non-linear regression analysis; the is data averaged from duplicate 8 point titrations and given +/- standard error.
###end p 42

